PERSPECTA

News from every angle

Back to headlines

Quantum BioPharma to Voluntarily Delist Class B Shares

The biotechnology firm announced plans to remove its Class B shares from the Canadian Securities Exchange, streamlining its listing structure.

1 Sept, 23:00 — 1 Sept, 23:00
PostShare